权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

14th International Workshop on Kaposi's Sarcoma-Associated Herpesvirus and Relate

第14届卡波西肉瘤相关疱疹病毒及相关国际研讨会

基本信息

批准号：
8204160
负责人：
Dean H Kedes
金额：
$ 0.2万
依托单位：
UNIVERSITY OF VIRGINIA
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-07-06 至 2012-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8204160
关键词：
African Animal Model Animals Applications Grants Area Biology Biotechnology Canada China Country Development Disease Doctor of Philosophy Educational workshop Elderly Epidemiology European Event Fees Finland Foundations France Funding Gene Expression Geographic Locations Germany Goals Group Meetings HIV Herpesviridae Human Human Herpesvirus 4 Human Herpesvirus 8 Immune Immune response Immunocompromised Host Individual Infection International Israel Kaposi Sarcoma Knowledge Lymphoma Macaca mulatta Malignant Neoplasms Methods Molecular Molecular Biology Multicentric Angiofollicular Lymphoid Hyperplasia Murine herpesvirus 68 Participant Pathology Pharmacologic Substance Population Prevention Request for Applications Research Rhadinovirus Running Saimiri Scandinavia Schools Scientist Uganda United Kingdom Universities Viral Viral Genes Viral Pathogenesis Virginia Virus Virus Diseases Woman cost effusion gamma-2 herpesvirus gammaherpesvirus man meetings member men programs reactivation from latency symposium tumor tumorigenesis tumorigenic virus pathogenesis working group

项目摘要

DESCRIPTION (provided by applicant): The 14th International Workshop on KSHV and Related Agents is organized by Dean Kedes, MD, PhD (USA) and Pdivi Ojala, PhD (Finland). This is an annual meeting for research scientists from around the world studying all aspects of the biology of Kaposi's sarcoma-associated herpes virus (KSHV). The aim is that they will share their recent findings, network and collaborate. KSHV is the most recently identified tumorigenic herpesvirus infecting man. It is the etiologic agent of Kaposi's sarcoma (KS) and also underlies primary effusion lymphoma and multicentric Castleman's disease. KS is a multifocal tumor observed in elderly Mediterranean men, the immunocompromised and untreated HIV-infected individuals. It is the most frequent tumor of HIV-infected individuals and, in certain African countries (e.g. Uganda), is the leading cancer of men. Contributions to the meeting from groups working on related gammaherpesviruses are also expected. These viruses include others infecting humans (Epstein Barr virus) and those infecting animals, such as murine herpesvirus- 68, rhesus rhadinovirus and herpes virus saimiri. The meeting will run for four days and will cover aspects such as molecular biology, molecular mechanisms of tumorigenesis, immune evasion, epidemiology and pathology. Delegates The scientific committee will consist of three members from the organizing committee, 11 out-of-town members, five of whom are European scientists, and four of whom are women. The entire committee represents diverse scientific expertise, geographic location and institutional affiliations. It is also predicted that there will be a diverse group of participants/delegates in attendance, as determined by attendance at the previous meeting in 2010. In addition to USA delegates, participants are anticipated from the United Kingdom, Canada, China, Scandinavia, France, Germany and Israel. The meeting will be held at The Conference and Events Center of the Hilton Helsinki Kalastajatorppa Hotel, Helsinki, Finland, August 12- 15, 2011. PUBLIC HEALTH RELEVANCE: KSHV is the most recently identified tumorigenic herpesvirus infecting man. It is the etiologic agent of Kaposi's sarcoma (KS) and also underlies primary effusion lymphoma and multicentric Castleman's disease. KS is a multifocal tumor observed in elderly Mediterranean men, the immunocompromised and untreated HIV-infected individuals. It is the most frequent tumor of HIV-infected individuals and, in certain African countries is the leading cancer of men.

描述（由申请人提供）：第14届KSHV和相关因子国际研讨会由Dean Kedes，MD，PhD（美国）和Pdivi Ojala，PhD（芬兰）组织。这是来自世界各地的研究科学家的年度会议，研究卡波西肉瘤相关疱疹病毒（KSHV）生物学的各个方面。目的是让他们分享最近的发现，建立网络并进行合作。KSHV是最近发现的一种感染人类的致瘤性疱疹病毒，它是卡波西肉瘤（KS）的病原体，也是原发性渗出性淋巴瘤和多中心Castleman病的基础。KS是一种多灶性肿瘤，见于地中海地区的老年男性、免疫功能低下和未经治疗的HIV感染者。它是艾滋病毒感染者最常见的肿瘤，在某些非洲国家（如乌干达），是男性的主要癌症。预计从事有关γ疱疹病毒工作的小组也将对会议作出贡献。这些病毒包括感染人类的其他病毒（爱泼斯坦巴尔病毒）和感染动物的病毒，如鼠疱疹病毒-68、恒河猴Rhadinovirus和松鼠猴疱疹病毒。会议将持续四天，将涵盖分子生物学、肿瘤发生的分子机制、免疫逃避、流行病学和病理学等方面。科学委员会将由组委会的3名成员、11名外地成员组成，其中5名是欧洲科学家，4名是女性。整个委员会代表了不同的科学专长、地理位置和机构联系。根据2010年上一次会议的出席情况，预计将有各种各样的与会者/代表出席会议。除美国代表外，预计与会者将来自英国、加拿大、中国、斯堪的纳维亚、法国、德国和以色列。会议将于2011年8月12日至15日在芬兰赫尔辛基的希尔顿赫尔辛基Kalastajatorppa酒店的会议和活动中心举行。公共卫生关系：KSHV是最近发现的一种感染人类的致瘤性疱疹病毒，它是卡波西肉瘤（KS）的病原体，也是原发性渗出性淋巴瘤和多中心Castleman病的基础。KS是一种多灶性肿瘤，见于地中海地区的老年男性、免疫功能低下和未经治疗的HIV感染者。它是艾滋病毒感染者最常见的肿瘤，在某些非洲国家是男性的主要癌症。